Comparison of disc diffusion, E-test, and broth microdilution methods for the determination of resistance to colistin, polymyxin B, and tigecycline in multi-resistant acinetobacter baumannii isolates;Çoǧul di̇rençli̇ acinetobacter baumannii izolatlarinda koli̇sti̇n, poli̇miksi̇n B ve ti̇gesi̇ kli̇n di̇renci̇ni̇n saptanmasinda di̇sk di̇füzyon, E-test ve buyyon mi̇krodi̇lüsyon yöntemleri̇ni̇n karşilaştirilmasi

Mikrobiyoloji Bulteni

Volumn 44, Issue 2, 2010, Pages 203-210

  Akin, F Ebru Özgür ^a   Bayram, Ayşen ^a   Balci, Idal ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

Acinetobacter baumannii; Antibiotic susceptibility; Colistin; Polymyxin B; Tigecydine

Indexed keywords

ANTIINFECTIVE AGENT; COLISTIN; DRUG DERIVATIVE; MINOCYCLINE; POLYMYXIN B; TIGECYCLINE;

ACINETOBACTER BAUMANNII; ARTICLE; CLASSIFICATION; COMPARATIVE STUDY; DRUG EFFECT; HUMAN; MICROBIOLOGICAL EXAMINATION; MULTIDRUG RESISTANCE; STANDARD;

ACINETOBACTER BAUMANNII; ANTI-BACTERIAL AGENTS; COLISTIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; POLYMYXIN B;

EID: 77952869034     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Akaiin H. Kolistin. ANKEM 2007; 21: 26-8.
2. Li J, Nation RL, Milne RW, Turnidge JD, Coulthard K. Evaluation of colistin as an agent against multi-resis-tant Gram-negative bacteria. Int J Antimicrob Agents 2005; 25:11-25.
3. Calik N, Akova M. Tigesiklin. ANKEM 2007; 21: 29-33.
4. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk susceptibility tests. Approved Standard M2-A9. 2007, 9th ed. CLSI, Wayne, PA.
5. Falagas ME, Koletsi PK, Bliziotis IA. The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aemginosa. J Med Microbiol 2006; 55:1619-29.
6. Bergogne-Berezin E, Towner KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev 1996; 9:148-65.
7. Towner K. The genus Acinetobacter. Prokaryotes 2006; 6: 746-58.
8. Falagas ME, Kasiakou SK. Colistin: The revival of polymyxins for the management of multidrug-resistant gram negative bacterial infections. Clin Infect Dis 2005; 40:1333-41.
9. Ulusoy S. Tigesiklin. ANKEM 2006; 20: 117-9.
10. Lo-Ten-Foe JR, de Smet AM, Diederen BM, Kluytmans JA, Keulen PH. Comparative evaluation of the VITEK 2, disk diffusion, E test, broth microdilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains. Antimicrob Agents Chemother 2007; 51: 3726-30.
11. Hawley J, Murray CK, Griffith ME, et al. Susceptibility of Acinetobacter strains isolated from deployed U.S. military personnel. Antimicrob Agents Chemother 2007; 51: 376-8.
12. Arroyo LA, Garda-Curiel A, Pachon-lbanez MA, et al. Reliability of the E-test method for detection of colistin resistance in clinical isolates of Acinetobacter baumannii.J Clin Microbiol 2005; 43: 903-5.
13. Mezzatesta ML, Trovato G, Gona F. In vitro activity of tigecydine and comparators against carbapenem-susceptible and resistant Acinetobacter baumannii clinical isolates in Italy. Ann Clin Microbiol Antimicrob 2008; 7: 4-7.
14. Lolans K, Rice TW, Munoz-Price SL, Quinn JP. Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40. Antimicrob Agents Chemother 2006; 50: 2941-5.
15. Song JG, Kee SY, Hwang IS, et al. In vitro activities of carbapenem/sulbactam combination, colistin, colis-tin/rifampicin combination and tigecydine against carbapenem-resistant Acinetobacter baumannii.J Antimicrob Chemother 2007; 60: 317-22.
16. Pachon-lbanez ME, Jimenez-Mejias ME, Pichardo C, Llanos AC, Pachon J. Activity of tigecydine (GAR-936) against Acinetobacter baumannii strains, including those resistant to imipenem. Antimicrob Agents Chemother 2004; 48: 4479-81.
17. Navon-Venezia S, Leavitt A, Carmeli Y. High tigecydine resistance in multidrug-resistant Acinetobacter baumannii. J Antimicrob Chemother 2007; 59: 772-4.
18. Akinci E, Mumcuoglu I, Öngörü P, et al. In vitro activity of tigecydine against Acinetobacter baumannii strains isolated from nosocomial infections. Turk J Med Sci 2008; 38: 583-6.
19. Tiengrim S, Tribuddharat C, Thamlikitkul V. In vitro activity of tigecydine against clinical isolates of multidrug-resistant Acinetobacter baumannii in Siriraj Hospital, Thailand.J Med Assoc Thai 2006; 89:102-5.